Astena Holdings Co., Ltd. Logo

Astena Holdings Co., Ltd.

Develops and sells chemicals, pharma, and ingredients for food, cosmetic, and industrial use.

8095 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
中央区日本橋本町四丁目8番2号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Astena Holdings Co., Ltd., formerly Iwaki & Co Ltd, is a diversified holding company established on June 1, 2021, following the transition of the IWAKI Group. The company operates through several core business segments: Fine Chemicals, Health & Beauty Care (HBC), Medical, Food, and Industrial Chemicals. Astena Holdings develops, manufactures, and wholesales a broad portfolio of products, including pharmaceuticals, medical devices, cosmetic ingredients, functional food ingredients, and specialty chemicals. A key subsidiary, Meltex, is a leading provider of surface finishing chemicals used in various industries, including semiconductors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-18 08:03
M&A Activity
臨時報告書
Japanese 28.5 KB
2025-07-11 08:07
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-07-11 08:06
Interim Report
半期報告書-第86期(2024/12/01-2025/11/30)
Japanese 245.6 KB
2025-03-06 07:04
Post-Annual General Meeting Information
臨時報告書
Japanese 23.9 KB
2025-02-27 08:04
Regulatory News Service
内部統制報告書-第85期(2023/12/01-2024/11/30)
Japanese 22.1 KB
2025-02-27 08:03
Regulatory News Service
確認書
Japanese 8.2 KB
2025-02-27 08:02
Annual Report
有価証券報告書-第85期(2023/12/01-2024/11/30)
Japanese 1.4 MB
2025-01-30 07:05
Regulatory News Service
臨時報告書
Japanese 18.7 KB
2024-07-12 08:06
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-07-12 08:05
Quarterly Report
四半期報告書-第85期第2四半期(2024/03/01-2024/05/31)
Japanese 249.6 KB
2024-04-12 08:13
Quarterly Report
確認書
Japanese 8.1 KB
2024-04-12 08:10
Quarterly Report
四半期報告書-第85期第1四半期(2023/12/01-2024/02/29)
Japanese 203.6 KB
2024-03-04 08:10
Regulatory News Service
臨時報告書
Japanese 25.0 KB
2024-02-28 08:35
Registration Form
確認書
Japanese 8.1 KB
2024-02-28 08:34
Governance Information
内部統制報告書-第84期(2022/12/01-2023/11/30)
Japanese 22.1 KB

Automate Your Workflow. Get a real-time feed of all Astena Holdings Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Astena Holdings Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
KOA SHOJI HOLDINGS CO.,LTD. Logo
Imports APIs and manufactures generic drugs for Japan's pharmaceutical industry.
Japan 9273
KOBAYASHI PHARMACEUTICAL  CO.,LTD. Logo
Manufactures OTC pharma, personal care, and household goods for niche consumer markets.
Japan 4967
Kohjin Bio Co., Ltd. Logo
A CDMO providing culture media & bioservices for cell therapy, research, and diagnostics.
Japan 177A
KOLON LIFE SCIENCE Inc. Logo
Develops gene therapies and manufactures APIs, providing global CDMO/CMO services.
South Korea 102940
Kolon TissueGene, Inc. Logo
Developing cell and gene therapies for orthopedic and degenerative disorders.
United States of America 950160
Develops animal health products and novel drugs for human cancer and autoimmune diseases.
South Korea 041960
KOREA ARLICO PHARM CO.,LTD. Logo
Manufactures generic drugs and provides CDMO services to a global market.
South Korea 260660
Develops and manufactures prescription (ETC) and over-the-counter (OTC) medicines for public health.
South Korea 014570
K Pharma,Inc. Logo
Develops iPS cell-based drugs and regenerative medicine for central nervous system disorders.
Japan 4896
Kringle Pharma,Inc. Logo
Develops regenerative HGF medicines for rare and intractable neurological diseases.
Japan 4884

Talk to a Data Expert

Have a question? We'll get back to you promptly.